Composition
- Active ingredients
- LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS EQ 50MG BASE/5ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS EQ 50MG BASE · CapsuleNDA012928-006 · Discontinued
- LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS EQ 100MG BASE · CapsuleNDA012928-004 · Discontinued
- LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS EQ 50MG BASE/5ML · SuspensionThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA012928.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Novrad
- Active substance
- levopropoxyphene napsylate anhydrous
- Route
- Oral
- Dosage form
- Suspension
- Applicant
- Lilly
- Status
- Discontinued
- FDA approval
- 21 Mar 1962
- Application
- NDA012928-002